 Home > Biochemistry News > Biotechnology News > For the first time, we won the exclusive global development and commercialization rights of Sanofi GIP receptor agonist

For the first time, we won the exclusive global development and commercialization rights of Sanofi GIP receptor agonist

 Last Update: 2021-12-31
 Source: Internet
 Author: User

Tags

glp 1 receptor agonist drugs

cd 1 2

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

On November 30, Vida Biotech announced that it has signed a global exclusive license agreement with Sanofi to obtain the global development and commercialization rights of Sanofi's long-acting glucose-dependent insulin-promoting polypeptide (GIP) receptor agonist project , The candidate drug is currently in the pre-clinical development stage

According to the terms of the agreement, Sanofi granted Xianweida the global exclusive rights to develop, manufacture and commercialize its GIP receptor agonist program for all relevant indications

GIP is a peptide hormone with multiple effects on metabolism, including increasing insulin secretion, regulating pancreatic β-cell function and regulating lipid metabolism

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.